International Stem Cell Corp., a California-based biotechnology company focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products, announced earlier today that Dr. Simon Craw, Executive Vice President of Business Development and Investor Relations, will be giving a presentation at the 2012 Southern California Investor Conference on Thursday, August 30, 2012, at 2:30 pm PT / 5:30 pm ET.
Held at the Marriott Hotel in Newport Beach, California, the conference is open to the public. Attendees will enjoy company presentations, a gourmet luncheon, free copy of California Stock Report, and much more. Investors who wish to arrange a meeting with International Stem Cell’s management team should contact Mark McPartland with MZ Group via email markmcp@mzgroup.us or phone 1-212-301-7130.
For additional information on ISCO, visit the company’s website at www.InternationalStemCell.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment